European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
Impact in
- Epidemiology 454
Classified as
- Authors
- C.D. Forbes
- Journal
- PubMed
In The Last Decade
doi.org/w86633684 →Countries where authors are citing European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
This map shows the geographic impact of European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. more than expected).
Fields of papers citing European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
This network shows the impact of European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke..
About European stroke prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.
This paper, published in 1997, received 1.0k indexed citations . Written by C.D. Forbes covering the research area of Epidemiology, Internal Medicine and Cardiology and Cardiovascular Medicine. It is primarily cited by scholars working on Cardiology and Cardiovascular Medicine (608 citations), Epidemiology (454 citations), Pulmonary and Respiratory Medicine (303 citations), Internal Medicine (227 citations) and Surgery (123 citations). Published in PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/w86633684.